Strategic incorporation of polarity in heme-displacing inhibitors of indoleamine-2,3-dioxygenase-1 (IDO1)

White C, McGowan MA, Zhou H, Sciammetta N, Fradera X, Lim J, Joshi EM, Andrews C, Nickbarg EB, Cowley P, Trewick S, Augustin M, Von Köenig K, Lesburg CA, Otte K, Knemeyer I, Woo H, Yu W, Cheng M, Spacciapoli P, Geda P, Song X, Smotrov N, Curran P, Heo MR, Abeywickrema P, Miller JR, Bennett DJ & Han Y
Choose the citation style.
White, C., McGowan, M. A., Zhou, H., Sciammetta, N., Fradera, X., Lim, J., … Han, Y. (2020). Strategic incorporation of polarity in heme-displacing inhibitors of indoleamine-2,3-dioxygenase-1 (IDO1). ACS Medicinal Chemistry Letters, 11(4), 550-557. https://doi.org/10.1021/acsmedchemlett.0c00010